🔎 Trials Near Me

홈 › 전이성 암 › 코네티컷

코네티컷의 전이성 암 임상 시험

전이성 암 관련 연구 27개가 코네티컷 내 여러 지역에서 참여자를 모집하고 있습니다.

코네티컷의 도시

공식 연구 텍스트(영어)

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Smilow Cancer Center at Yale New Haven Hospital, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05382559

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, New Have
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07229313

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Yale-New Haven Hospital, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • UConn Health, Farmington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Yale Cancer Center, New Haven
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Yale University School of Medicine, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

  • Yale University, New Haven
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06311214

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, New Haven
피험자 모집 중1/2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07038343

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Smilow Cancer Hospital at Yale New Haven, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

  • Yale Cancer Center-Yale University, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07213817

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • Yale Cancer Center, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07029399

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

  • Avenzo Therapeutics Recruiting Site, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT07193511

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Yale University School of Medicine, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

  • Yale University, New Haven
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT05691491

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

  • Crinetics Study Site, New Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07129252

A Study of ASP1002 in Adults for Treatment of Solid Tumors

  • Yale University Cancer Center, New Haven
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut, Plainville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT05719558

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

  • Exelixis Clinical Site #4, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 24. 업데이트됨 · NCT06952010

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Smilow Cancer Hospital (Yale University), New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

  • Yale University, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT06917079

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

  • Yale School of Medicine, North Haven
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT06413680

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Yale School of Medicine - Smilow Cancer Hospital, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06064877

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

  • Yale Cancer Center, New Haven
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 2. 6. 업데이트됨 · NCT06127407

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • Yale - New Haven Hospital, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 15. 업데이트됨 · NCT06234605

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Hartford Hospital (site 210), Hartford
피험자 모집 중1/2상
18세 ~ 80세 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Hartford
  • Massive Bio SYNERGY-AI site, Norwalk
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

  • Yale Cancer Center, New Haven
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 25. 업데이트됨 · NCT05808634

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.